Abiopharma

🔍 Rudy Mitchell Austin (Director)

Company: BONK, INC. (BNKK)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Acquired 12,000 shares of Common Stock at $1.37 per share (Direct)
  Date: 2026-06-10 | Code: P | equity_swap_involved: 0 | shares_owned_after: 63,341.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-10 | Code: H | nature_of_ownership: By Lucky Dog Holdings | shares_owned_after: 1,483,459.00 | Footnotes: F3
• Holds 0 shares of Series C Convertible Preferred Stock (Direct)
  Date: 2026-06-10 | Code: H | nature_of_ownership: By Lucky Dog Holdings | shares_owned_after: 3,568,124.00 | Footnotes: F4, F3

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.39 from June 10, 2026 to June 12, 2026. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F2: Represents securities held by Nom Capital ULC in which the reporting person holds 100% equity interest. The reporting person has voting and investment power over all securities owned by Nom Capital ULC.
• F3: Represents securities held by Lucky Dog Holdings, an exempted company incorporated in the Cayman Islands, in which the reporting person holds a significant equity interest. The reporting person has voting and investment power over all securities owned by Lucky Dog Holdings.
• F4: Lucky Dog Holdings acquired 135,000 shares of Series C Convertible Preferred Stock which can be converted into 726,345 shares of common stock.